X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (248) 248
humans (245) 245
female (119) 119
male (106) 106
pulmonary embolism (105) 105
middle aged (98) 98
peripheral vascular disease (96) 96
aged (95) 95
hematology (94) 94
abridged index medicus (88) 88
venous thromboembolism (77) 77
thromboembolism (74) 74
pulmonary embolism - diagnosis (73) 73
adult (68) 68
medicine, general & internal (68) 68
diagnosis (66) 66
anticoagulants - therapeutic use (61) 61
risk factors (60) 60
venous thrombosis (59) 59
thrombosis (57) 57
anticoagulants (55) 55
life sciences (55) 55
human health and pathology (51) 51
deep-vein thrombosis (48) 48
aged, 80 and over (46) 46
d-dimer (46) 46
pulmonary-embolism (46) 46
predictive value of tests (43) 43
fibrin fibrinogen degradation products - analysis (40) 40
management (39) 39
prevention (38) 38
ultrasonography (38) 38
risk (35) 35
sensitivity and specificity (35) 35
recurrence (34) 34
treatment outcome (32) 32
probability (30) 30
hemorrhage - chemically induced (29) 29
prognosis (29) 29
prospective studies (28) 28
care and treatment (26) 26
venous thrombosis - diagnosis (26) 26
drug therapy (25) 25
pulmonary embolism - blood (24) 24
research (24) 24
fibrin fibrinogen degradation products (23) 23
molecular-weight heparin (23) 23
anticoagulants - adverse effects (22) 22
venous thromboembolism - drug therapy (22) 22
anticoagulants - administration & dosage (21) 21
mortality (21) 21
outpatients (21) 21
time factors (21) 21
deep vein thrombosis (20) 20
embolisms (20) 20
follow-up studies (20) 20
prevalence (20) 20
pulmonary embolism - diagnostic imaging (20) 20
risk assessment (20) 20
cancer (19) 19
clinical probability (19) 19
rivaroxaban (19) 19
venous thrombosis - diagnostic imaging (19) 19
algorithms (18) 18
deep venous thrombosis (18) 18
internal medicine (18) 18
pulmonary embolism - mortality (18) 18
surgery (18) 18
therapy (18) 18
cardiac & cardiovascular systems (17) 17
decision support techniques (17) 17
fibrinolytic agents - therapeutic use (17) 17
health risk assessment (17) 17
patients (17) 17
respiratory system (17) 17
venous thrombosis - drug therapy (17) 17
age factors (16) 16
analysis (16) 16
angiography (16) 16
anticoagulation (16) 16
health aspects (16) 16
heparin, low-molecular-weight - therapeutic use (16) 16
retrospective studies (16) 16
venous thromboembolism - prevention & control (16) 16
warfarin (16) 16
administration, oral (15) 15
biomarkers - blood (15) 15
pulmonary embolism - drug therapy (15) 15
pulmonary embolism - epidemiology (15) 15
pulmonary embolism - etiology (15) 15
switzerland (15) 15
computed-tomography (14) 14
diagnosis, differential (14) 14
fibrin fibrinogen degradation products - metabolism (14) 14
cost-benefit analysis (13) 13
leg - blood supply (13) 13
metaanalysis (13) 13
registries (13) 13
acute disease (12) 12
adolescent (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 03/2014, Volume 311, Issue 11, pp. 1117 - 1124
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 09/2009, Volume 151, Issue 6, p. JC3
  Bounameaux comments on a study by Prandoni el at conducted to assess whether ultrasonography-guided oral anticoagulant therapy (OAT) reduced recurrent venous... 
Clinical trials | Patient safety | Drug therapy | Thrombosis | Risk factors
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9621, pp. 1343 - 1352
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 13, pp. 1211 - 1222
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2005, Volume 352, Issue 17, pp. 1760 - 1768
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article